Henderson Molly
CIK 0001363812
Chief Financial Officer
Filings
21
Latest Apr 8, 2025
Issuers covered
2
Showing
21 of 21
Page 1
Track record
15 of 15 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 15 | 67% | +3.2% | +9.1% | +50.7% | -60.3% |
| 90 days | 15 | 47% | -9.6% | -11.6% | +42.6% | -77.8% |
| 180 days | 15 | 47% | -18.6% | -15.3% | +47.8% | -138.4% |
| 365 days | 15 | 40% | -29.9% | -26.5% | +61.7% | -137.2% |
Issuers
Companies where Henderson Molly has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 20 | Apr 8, 2025 |
| URGN | Urogen Pharma Ltd. | 1 | Feb 2, 2022 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|